{
  "drug_name": "Morphine",
  "url": "https://wikem.org/wiki/Morphine",
  "scraped_at": "2026-01-10T02:46:31.373694",
  "sections": {
    "General": "Type:\nOpioids\nDosage Forms: 5, 10, 15, 20, 30, 45, 50, 60, 75, 80, 90, 100, 120, 200, 0.5/ml, 1/ml, 2/ml, 4/ml. 5/ml, 8/ml, 10/ml, 15/ml, 25/ml, 50/ml,\nCommon Trade Names: Astramorph, AVINza, Duramorph, Infumorph, Kadian, MS contin",
    "Adult_Dosing": "Acute pain (Moderate to severe):\nOral: 10-30mg q4hr PRN\nIM: 5-15mg\nTypically not recommended due to erratic absorption\nIf utilized, no more than one IM dose should be given, due to the danger of \"stacking\" doses (may lead to respiratory compromise)\nIV: 0.1 mg/kg bolus followed by 0.05 mg/kg q15-20 min until pain controlled\nHold further doses for respiratory depression\nDosed according to ideal body weight\nAMI: 4-8mg q5-15min PRN\nCritically ill: 2-4mg q1-2hr or 4-8mg q3-4hr PRN\nContinuous infusion IV, SC: 0.8-10mg/hr (up to 80mg/hr)\nCritically ill: 2-30mg/hr\nPCA 0.5-2.5mg q5-10min PRN\nEpidural (Preservative free)\nSingle dose: 30-100mcg/kg\nContinuous infusion: 0.2-0.4mg/hr\nContinuous microinfusion: 3.5-10mg over 24hrs, titrate to effect (max ~30mg)\nIntrathecal (Preservative free)\nSingle dose: 0.1-03.mg\nContinuous microinfusion: 0.2-10mg over 24 hours (max ~20mg)\nRectal: 10-20mg q3-4hr",
    "Pediatric_Dosing": "Children >6months and <50kg\nAcute pain (Moderate to severe)\nOral: 0.15-0.3mg/kg q3-4hr PRN\nIM, SC: 0.1-0.2mg/kg\nIV: 0.05-0.3mg/kg q3-4hr PRN (not to exceed 10mg/dose)\nContinuous infusion: 10-30mcg/kg/hr\nPCA 0.01-0.03mg/kg/dose and 0-0.03mg/kg/hr",
    "Special_Populations": "Pregnancy Rating\n: C\nLactation: Enters breast milk\nRenal Dosing\nCrCl 10-50: 75% of normal dose\nCrCl <10: 50% of normal dose\nHD: Child 50%, adult no adjustment\nPD: Child 50%\nCRRT: Child and adults 75%\nHepatic Dosing: No adjustment generally (cirrhosis can consider dose adjustment)",
    "Contraindications": "Allergy to class/drug",
    "Adverse_Reactions": "Serious\nCirculatory depression,\nshock\n,\ncardiac arrest\nBradycardia\n, hypotension\nCNS depression\n, sedation\nApnea, respiratory arrest/depression\nAnaphylaxis, laryngospasm\nCommon\nDependence\nADH release, hypogonadism\nDrowsiness, dizziness, confusion, headache\nPruritis\nXerostomia, constipation, vomiting\nUrinary retention\nPancytopenia\nWeakness\nHypoxia\nHistamine release, urticaria\nAfib\n,\ntachycardia\n, edema,\nchest pain\nAbdominal pain",
    "Pharmacology": "Half-life: Immediate release 2-4hrs; Avinza 24hrs; Kadian 11-13hrs\nMetabolism: Hepatic\nExcretion: Urine and feces\nMechanism of Action:\nBinds to opioid receptors in CNS\nInhibits ascending pain pathways\nAlters perception and response to pain\nProduces CNS depression"
  }
}